MASTROMARINO, VITTORIA
MASTROMARINO, VITTORIA
DIPARTIMENTO DI MEDICINA SPERIMENTALE
[Role of adherence to chronic drug therapy in patients with cardiovascular disease: an Italian intersocietary consensus document].
2014 Volpe, Massimo; Degli Esposti, L; Romeo, F; Trimarco, B; Bovenzi, Fm; Mastromarino, Vittoria; Battistoni, Allegra
Anemia and heart failure. Is there still a role for erythropoiesis-stimulating agents?
2017 Volpe, Massimo; Mastromarino, Vittoria
Arterial thrombotic events and acute coronary syndromes with cancer drugs: Are growth factors the missed link? What both cardiologist and oncologist should know about novel angiogenesis inhibitors
2013 E., Conti; Romiti, Adriana; Musumeci, Maria Beatrice; Passerini, Jasmine; L., Zezza; Mastromarino, Vittoria; C., D'Antonio; Marchetti, Paolo; Paneni, Francesco; Autore, Camillo; Volpe, Massimo
Blood Pressure Levels at the Time of Percutaneous Coronary Revascularization and Risk of Coronary In-Stent Restenosis
2015 Tocci, Giuliano; Barbato, Emanuele; Coluccia, Roberta; Modestino, Anna; Pagliaro, BENIAMINO ROSARIO; Mastromarino, Vittoria; Giovannelli, Francesca; Berni, Andrea; Volpe, Massimo
Cardiopulmonary exercise test and sudden cardiac death risk in hypertrophic cardiomyopathy
2016 Magri', Damiano; Limongelli, Giuseppe; Re, Federica; Agostoni, Piergiuseppe; Zachara, Elisabetta; Correale, Michele; Mastromarino, Vittoria; Santolamazza, Caterina; Casenghi, Matteo; Pacileo, Giuseppe; Valente, Fabio; Musumeci, Beatrice; Maruotti, Antonello; Volpe, Massimo; Autore, Camillo
Clinical and prognostic impact of chronotropic incompetence in patients with hypertrophic cardiomyopathy
2018 Magri, Damiano; Agostoni, Piergiuseppe; Sinagra, Gianfranco; Re, Federica; Correale, Michele; Limongelli, Giuseppe; Zachara, Elisabetta; Mastromarino, Vittoria; Santolamazza, Caterina; Casenghi, Matteo; Pacileo, Giuseppe; Valente, Fabio; Morosin, Marco; Musumeci, Beatrice; Pagannone, Erika; Maruotti, Antonello; Uguccioni, Massimo; Volpe, Massimo; Autore, Camillo
Erythropoiesis-stimulating agents in heart failure: Leave it or re-take it?
2015 Volpe, Massimo; Santolamazza, Caterina; Mastromarino, Vittoria
Erythropoietin and the heart: facts and perspectives.
2011 Mastromarino, Vittoria; Volpe, Massimo; Musumeci, Maria Beatrice; Autore, Camillo; Elena, Conti
Erythropoietin in cardiac disease: effective or harmful?
2013 Mastromarino, Vittoria; Musumeci, Maria Beatrice; Elena, Conti; Tocci, Giuliano; Volpe, Massimo
Genotype in hypertrophic cardiomyopathy: clinical implications
2020 Mastromarino, Vittoria
Heart failure progression in hypertrophic cardiomyopathy, Possible insights from cardiopulmonary exercise testing
2016 Magri', Damiano; Re, Federica; Limongelli, Giuseppe; Agostoni, Piergiuseppe; Zachara, Elisabetta; Correale, Michele; Mastromarino, Vittoria; Santolamazza, Caterina; Casenghi, Matteo; Pacileo, Giuseppe; Valente, Fabio; Morosin, Marco; Musumeci, Maria Beatrice; Pagannone, Erika; Maruotti, Antonello; Uguccioni, Massimo; Volpe, Massimo; Autore, Camillo
IGF-1 and atherothrombosis: relevance to pathophysiology and therapy
2011 Elena, Conti; Musumeci, Maria Beatrice; Marco, De giusti; Eleonora, Dito; Mastromarino, Vittoria; Autore, Camillo; Volpe, Massimo
Integrated preclinical cardiovascular prevention: a new paradigm to face growing challenges of cardiovascular disease
2015 Volpe, Massimo; Mastromarino, Vittoria; Battistoni, Allegra
Monotherapy and Dual Combination Therapies Based on Olmesartan: A Comprehensive Strategy to Improve Blood Pressure Control
2017 Volpe, Massimo; Santolamazza, Caterina; Mastromarino, Vittoria; Coluccia, Roberta; Battistoni, Allegra; Tocci, Giuliano
Myocardial Repolarization Dispersion and Late Gadolinium Enhancement in Patients With Hypertrophic Cardiomyopathy
2014 Magri', Damiano; DE CECCO, CARLO NICOLA; Piccirillo, Gianfranco; Mastromarino, Vittoria; Serdoz, Andrea; Muscogiuri, Giuseppe; Ricotta, Agnese; Gregori, Mario; Marino, Laura; Cauti, FILIPPO MARIA; Pagannone, Erika; Musumeci, Maria Beatrice; Antonello, Maruotti; Autore, Camillo
Natriuretic peptides and volume handling in heart failure. The paradigm of a new treatment
2016 Volpe, Massimo; Battistoni, Allegra; Mastromarino, Vittoria
Novel α-galactosidase A mutation in patients with severe cardiac manifestations of Fabry disease
2014 Giovanni, Duro; Musumeci, Maria Beatrice; Paolo, Colomba; Carmela, Zizzo; Giuseppe, Albeggiani; Mastromarino, Vittoria; Volpe, Massimo; Autore, Camillo
Polypharmacy in Heart Failure Patients
2014 Mastromarino, Vittoria; Casenghi, Matteo; Marco, Testa; Erica, Gabriele; Coluccia, Roberta; Rubattu, Speranza Donatella; Volpe, Massimo
Pulmonary hypertension and clinical correlates in hypertrophic cardiomyopathy
2017 Musumeci, Maria Beatrice; Mastromarino, Vittoria; Casenghi, Matteo; Tini, Giacomo; Francia, Pietro; Maruotti, Antonello; Romaniello, Antonella; Magrì, Damiano; Lillo, Rosa; Adduci, Carmen; Volpe, Massimo; Autore, Camillo
QT spatial dispersion and sudden cardiac death in hypertrophic cardiomyopathy. time for reappraisal.
2017 Magri', Damiano; Santolamazza, Caterina; Limite, LUCA ROSARIO; Mastromarino, Vittoria; Casenghi, Matteo; Orlando, P; Pagannone, Erika; Musumeci, Maria Beatrice; Maruotti, Antonello; Ricotta, Agnese; Oliviero, G; Piccirillo, Gianfranco; Volpe, Massimo; Autore, Camillo
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| [Role of adherence to chronic drug therapy in patients with cardiovascular disease: an Italian intersocietary consensus document]. | 2014 | Volpe, Massimo; Degli Esposti, L; Romeo, F; Trimarco, B; Bovenzi, Fm; Mastromarino, Vittoria; Battistoni, Allegra | |
| Anemia and heart failure. Is there still a role for erythropoiesis-stimulating agents? | 2017 | Volpe, Massimo; Mastromarino, Vittoria | |
| Arterial thrombotic events and acute coronary syndromes with cancer drugs: Are growth factors the missed link? What both cardiologist and oncologist should know about novel angiogenesis inhibitors | 2013 | E., Conti; Romiti, Adriana; Musumeci, Maria Beatrice; Passerini, Jasmine; L., Zezza; Mastromarino, Vittoria; C., D'Antonio; Marchetti, Paolo; Paneni, Francesco; Autore, Camillo; Volpe, Massimo | |
| Blood Pressure Levels at the Time of Percutaneous Coronary Revascularization and Risk of Coronary In-Stent Restenosis | 2015 | Tocci, Giuliano; Barbato, Emanuele; Coluccia, Roberta; Modestino, Anna; Pagliaro, BENIAMINO ROSARIO; Mastromarino, Vittoria; Giovannelli, Francesca; Berni, Andrea; Volpe, Massimo | |
| Cardiopulmonary exercise test and sudden cardiac death risk in hypertrophic cardiomyopathy | 2016 | Magri', Damiano; Limongelli, Giuseppe; Re, Federica; Agostoni, Piergiuseppe; Zachara, Elisabetta; Correale, Michele; Mastromarino, Vittoria; Santolamazza, Caterina; Casenghi, Matteo; Pacileo, Giuseppe; Valente, Fabio; Musumeci, Beatrice; Maruotti, Antonello; Volpe, Massimo; Autore, Camillo | |
| Clinical and prognostic impact of chronotropic incompetence in patients with hypertrophic cardiomyopathy | 2018 | Magri, Damiano; Agostoni, Piergiuseppe; Sinagra, Gianfranco; Re, Federica; Correale, Michele; Limongelli, Giuseppe; Zachara, Elisabetta; Mastromarino, Vittoria; Santolamazza, Caterina; Casenghi, Matteo; Pacileo, Giuseppe; Valente, Fabio; Morosin, Marco; Musumeci, Beatrice; Pagannone, Erika; Maruotti, Antonello; Uguccioni, Massimo; Volpe, Massimo; Autore, Camillo | |
| Erythropoiesis-stimulating agents in heart failure: Leave it or re-take it? | 2015 | Volpe, Massimo; Santolamazza, Caterina; Mastromarino, Vittoria | |
| Erythropoietin and the heart: facts and perspectives. | 2011 | Mastromarino, Vittoria; Volpe, Massimo; Musumeci, Maria Beatrice; Autore, Camillo; Elena, Conti | |
| Erythropoietin in cardiac disease: effective or harmful? | 2013 | Mastromarino, Vittoria; Musumeci, Maria Beatrice; Elena, Conti; Tocci, Giuliano; Volpe, Massimo | |
| Genotype in hypertrophic cardiomyopathy: clinical implications | 2020 | Mastromarino, Vittoria | |
| Heart failure progression in hypertrophic cardiomyopathy, Possible insights from cardiopulmonary exercise testing | 2016 | Magri', Damiano; Re, Federica; Limongelli, Giuseppe; Agostoni, Piergiuseppe; Zachara, Elisabetta; Correale, Michele; Mastromarino, Vittoria; Santolamazza, Caterina; Casenghi, Matteo; Pacileo, Giuseppe; Valente, Fabio; Morosin, Marco; Musumeci, Maria Beatrice; Pagannone, Erika; Maruotti, Antonello; Uguccioni, Massimo; Volpe, Massimo; Autore, Camillo | |
| IGF-1 and atherothrombosis: relevance to pathophysiology and therapy | 2011 | Elena, Conti; Musumeci, Maria Beatrice; Marco, De giusti; Eleonora, Dito; Mastromarino, Vittoria; Autore, Camillo; Volpe, Massimo | |
| Integrated preclinical cardiovascular prevention: a new paradigm to face growing challenges of cardiovascular disease | 2015 | Volpe, Massimo; Mastromarino, Vittoria; Battistoni, Allegra | |
| Monotherapy and Dual Combination Therapies Based on Olmesartan: A Comprehensive Strategy to Improve Blood Pressure Control | 2017 | Volpe, Massimo; Santolamazza, Caterina; Mastromarino, Vittoria; Coluccia, Roberta; Battistoni, Allegra; Tocci, Giuliano | |
| Myocardial Repolarization Dispersion and Late Gadolinium Enhancement in Patients With Hypertrophic Cardiomyopathy | 2014 | Magri', Damiano; DE CECCO, CARLO NICOLA; Piccirillo, Gianfranco; Mastromarino, Vittoria; Serdoz, Andrea; Muscogiuri, Giuseppe; Ricotta, Agnese; Gregori, Mario; Marino, Laura; Cauti, FILIPPO MARIA; Pagannone, Erika; Musumeci, Maria Beatrice; Antonello, Maruotti; Autore, Camillo | |
| Natriuretic peptides and volume handling in heart failure. The paradigm of a new treatment | 2016 | Volpe, Massimo; Battistoni, Allegra; Mastromarino, Vittoria | |
| Novel α-galactosidase A mutation in patients with severe cardiac manifestations of Fabry disease | 2014 | Giovanni, Duro; Musumeci, Maria Beatrice; Paolo, Colomba; Carmela, Zizzo; Giuseppe, Albeggiani; Mastromarino, Vittoria; Volpe, Massimo; Autore, Camillo | |
| Polypharmacy in Heart Failure Patients | 2014 | Mastromarino, Vittoria; Casenghi, Matteo; Marco, Testa; Erica, Gabriele; Coluccia, Roberta; Rubattu, Speranza Donatella; Volpe, Massimo | |
| Pulmonary hypertension and clinical correlates in hypertrophic cardiomyopathy | 2017 | Musumeci, Maria Beatrice; Mastromarino, Vittoria; Casenghi, Matteo; Tini, Giacomo; Francia, Pietro; Maruotti, Antonello; Romaniello, Antonella; Magrì, Damiano; Lillo, Rosa; Adduci, Carmen; Volpe, Massimo; Autore, Camillo | |
| QT spatial dispersion and sudden cardiac death in hypertrophic cardiomyopathy. time for reappraisal. | 2017 | Magri', Damiano; Santolamazza, Caterina; Limite, LUCA ROSARIO; Mastromarino, Vittoria; Casenghi, Matteo; Orlando, P; Pagannone, Erika; Musumeci, Maria Beatrice; Maruotti, Antonello; Ricotta, Agnese; Oliviero, G; Piccirillo, Gianfranco; Volpe, Massimo; Autore, Camillo |